Advertisement

Heart Valve Surgery and the Antiphospholipid Syndrome

  • Carlos A. MestresEmail author
  • Cecilia Marcacci
  • Gerard Espinosa
  • Jose L Pomar
  • Andrea Colli
  • Ricard Cervera
Chapter
  • 1.2k Downloads

Abstract

Possible role of associated antiplatelets

Keywords

Systemic Lupus Erythematosus Systemic Lupus Erythematosus Patient Infective Endocarditis Valvular Lesion Valve Lesion 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Lillehei CW, Cohen M, Warden HE, Varco RL. The direct-vision intracardiac correction of congenital anomalies by controlled cross circulation; results in thirty-two patients with ventricular septal defects, tetralogy of Fallot, and atrioventricularis communis defects. Surgery. 1955;38:11–29.PubMedGoogle Scholar
  2. 2.
    Kirklin JW, Du Shane JW, Patrick RT, Donald DE, Hetzel PS, Harshbarger HG, et al. Intracardiac surgery with the aid of a mechanical pump-oxygenator system (Gibbon type): report of eight cases. Proc Staff Meet Mayo Clin. 1955;30:201–6.PubMedGoogle Scholar
  3. 3.
    Byrne JG, Leacche M. The American Heart Association/American College of Cardiology Foundation guideline for coronary artery bypass grafting: 2011 updates. J Thorac Cardiovasc Surg. 2012;143:35–6.PubMedCrossRefGoogle Scholar
  4. 4.
    Kurlansky PA, Argenziano M, Dunton R, Lancey R, Nast E, Stewart A, et al. Quality, not volume, determines outcome of coronary artery bypass surgery in a university-based community hospital network. J Thorac Cardiovasc Surg. 2012;143:287–93. Epub 2011 Nov 20.PubMedCrossRefGoogle Scholar
  5. 5.
    Espinosa G, Cervera R. Antiphospholipid syndrome: frequency, main causes and risk factors of mortality. Nat Rev Rheumatol. 2010;6:296–300.PubMedCrossRefGoogle Scholar
  6. 6.
    Cervera R, Piette JC, Font J, Khamashta MA, Shoenfeld Y, Camps MT, et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum. 2002;46:1019–27.PubMedCrossRefGoogle Scholar
  7. 7.
    Asherson RA. The catastrophic antiphospholipid syndrome syndrome. J Rheumatol. 1992;19:508–12.PubMedGoogle Scholar
  8. 8.
    Cervera R, Bucciarelli S, Plasín MA, Gómez-Puerta JA, Plaza J, Pons-Estel G, et al. Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of a series of 280 patients from the “CAPS Registry”. J Autoimmun. 2009;32:240–5.PubMedCrossRefGoogle Scholar
  9. 9.
    Asherson RA, Cervera R, de Groot P, Erkan D, Boffa MC, Piette JC, et al. Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines. Lupus. 2003;12:530–4.PubMedCrossRefGoogle Scholar
  10. 10.
    Cervera R, Font J, Gómez-Puerta JA, Espinosa G, Cucho M, Bucciarelli S, et al. Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome. Ann Rheum Dis. 2005;64:1205–9.PubMedCrossRefGoogle Scholar
  11. 11.
    Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Arthritis Rheum. 1999;42:1309–11.PubMedCrossRefGoogle Scholar
  12. 12.
    Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4:295–306.PubMedCrossRefGoogle Scholar
  13. 13.
    Espinosa G, Fernández de Orueta L, Lluch E, Polvorosa MA, Soro S, Cervera R. Task force report on non-citeria manifestations: cardiac valve disease. In: Erkan D, Pierangeli SS, editors. Antiphospholipid syndrome: insights and highlights from the 13th International Congress on antiphospholipid antibodies. New York: Springer; 2012.Google Scholar
  14. 14.
    Cervera R, Khamashta MA, Shoenfeld Y, et al. Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients. Ann Rheum Dis. 2009;68:1428–32.PubMedCrossRefGoogle Scholar
  15. 15.
    Cervera R, Tektonidou MG, Espinosa G, et al. Task force on catastrophic Antiphospholipid Syndrome (APS) and non-criteria APS manifestations (I): catastrophic APS, APS nephropathy and heart valve lesions. Lupus. 2011;20:165–73.PubMedCrossRefGoogle Scholar
  16. 16.
    Nesher G, Ilany J, Rosenmann D, Abraham AS. Valvular dysfunction in antiphospholipid syndrome: prevalence, clinical features, and treatment. Semin Arthritis Rheum. 1997;27:27–35.PubMedCrossRefGoogle Scholar
  17. 17.
    Roldan CA, Shively BK, Lau CC, Gurule FT, Smith EA, Crawford MH. Systemic lupus erythematosus valve disease by transesophageal echocardiography and the role of antiphospholipid antibodies. J Am Coll Cardiol. 1992;20:1127–34.PubMedCrossRefGoogle Scholar
  18. 18.
    Gabrielli F, Alcini E, Di Prima MA, Mazzacurati G, Masala C. Cardiac valve involvement in systemic lupus erythematosus and primary antiphospholipid syndrome: lack of correlation with antiphospholipid antibodies. Int J Cardiol. 1995;51:117–26.PubMedCrossRefGoogle Scholar
  19. 19.
    Espínola-Zavaleta N, Vargas-Barron J, Comenares-Galvis T, et al. Echocardiographic evaluation of patients with primary antiphospholipid syndrome. Am Heart J. 1999;137:973–9.PubMedCrossRefGoogle Scholar
  20. 20.
    Turiel M, Sarzi-Puttini P, Peretti R, et al. Five-year follow-up by transesophageal echocardiographic studies in primary antiphospholipid syndrome. Am J Cardiol. 2005;96:574–9.PubMedCrossRefGoogle Scholar
  21. 21.
    Perez-Villa F, Font J, Azqueta M, et al. Severe valvular regurgitation and antiphospholipid antibodies in systemic lupus erythematosus: a prospective, long-term, follow up study. Arthritis Care Res. 2005;53:460–7.CrossRefGoogle Scholar
  22. 22.
    Pardos-Gea J, Ordi-Ros J, Avegliano G, et al. Echocardiography at diagnosis of antiphospholipid syndrome provides prognostic information on valvular disease evolution and identifies two subtypes of patients. Lupus. 2010;19:575–82.PubMedCrossRefGoogle Scholar
  23. 23.
    Lockshin M, Tenedios F, Petri M, et al. Cardiac disease in the antiphospholipid syndrome: recommendations for treatment. Committee consensus report. Lupus. 2003;12:518–23.PubMedCrossRefGoogle Scholar
  24. 24.
    Colli A, Mestres CA, Espinosa G, Plasín MA, Pomar JL, Font J, et al. Heart valve surgery in patients with the antiphospholipid syndrome: analysis of a series of nine cases. Eur J Cardiothorac Surg. 2010;37:154–8.PubMedCrossRefGoogle Scholar
  25. 25.
    Alvarez-Blanco A, Egurbide-Arberas MV, Aguirre-Errasti C. Severe valvular heart disease in a patient with primary antiphospholipid syndrome. Lupus. 1994;3:433–4.PubMedGoogle Scholar
  26. 26.
    Schumacher M, Eber B, Dusleag J, Fruhwald FM, Zweiker R, Pokan R, et al. Thrombosis of a prosthetic mitral valve in the anticardiolipin syndrome. Dtsch Med Wochenschr. 1995;120:795–8.PubMedCrossRefGoogle Scholar
  27. 27.
    Sakaguchi G, Minami K, Nakayama S, Tsuneyoshi H. Aortic valve replacement after previous coronary artery bypass grafting in a patient with antiphospholipid syndrome. Jpn J Thorac Cardiovasc Surg. 1998;46:257–9.PubMedCrossRefGoogle Scholar
  28. 28.
    Myers GJ, Hirsch GM. Double valve replacement in a patient with anticardiolipin antibody syndrome. Perfusion. 1999;14:397–401.PubMedCrossRefGoogle Scholar
  29. 29.
    Matsuyama K, Ueda Y, Ogino H, Sugita T, Matsubayashi K, Nomoto T, et al. Aortic valve replacement for aortic regurgitation in a patient with primary antiphospholipid syndrome. Jpn Circ J. 1999;63:725–6.PubMedCrossRefGoogle Scholar
  30. 30.
    Hasegawa R, Kitahara H, Watanabe K, Kuroda H, Amano J. Mitral stenosis and regurgitation with systemic lupus erythematosus and antiphospholipid antibody syndrome. Jpn J Thorac Cardiovasc Surg. 2001;49:711–3.PubMedCrossRefGoogle Scholar
  31. 31.
    Kurushima A, Fukata Y, Horike K, Kanoh M. A difficult case of antiphospholipid syndrome with repeated restenosis of coronary artery and graft. Kyobu Geka. 2002;55:883–6.PubMedGoogle Scholar
  32. 32.
    Berkun Y, Elami A, Meir K, Mevorach D, Naparstek Y. Increased morbidity and mortality in patients with antiphospholipid syndrome undergoing valve replacement surgery. J Thorac Cardiovasc Surg. 2004;127:414–20.PubMedCrossRefGoogle Scholar
  33. 33.
    Herrmann M, Keysser G, Seige M, Holzhausen HJ, Silber RE, Diez C. Severe, non-infectious mitral valve endocarditis after mitral valve reconstruction in a 32-year old female with primary antiphospholipid syndrome. Z Kardiol. 2004;93:546–54.PubMedCrossRefGoogle Scholar
  34. 34.
    Massoudy P, Cetin SM, Thielmann M, Kienbaum P, Piotrowski JA, Marggraf G, et al. Antiphospholipid syndrome in cardiac surgery-an underestimated coagulation disorder? Eur J Cardiothorac Surg. 2005;28:133–7.PubMedCrossRefGoogle Scholar
  35. 35.
    Sasahashi N, Harada H, Saji Y, Marui A, Nishina T, Komeda M. Aortic valve replacement for aortic regurgitation in a patient with antiphospholipid antibody syndrome. Gen Thorac Cardiovasc Surg. 2007;55:293–6.PubMedCrossRefGoogle Scholar
  36. 36.
    Einav E, Gitig A, Marinescu LM, Tanaka KE, Spevack DM. Valvulitis requiring triple valve surgery as an initial presentation of systemic lupus erythematosus. J Am Soc Echocardiogr. 2007;20(11):1315.e1–3. Epub 2007 Jun 27.CrossRefGoogle Scholar
  37. 37.
    Hegde VA, Vivas Y, Shah H, Haybron D, Srinivasan V, Dua A, et al. Cardiovascular surgical outcomes in patients with the antiphospholipid syndrome–a case-series. Heart Lung Circ. 2007;16:423–7.PubMedCrossRefGoogle Scholar
  38. 38.
    Wieteska M, Szturmowicz M, Kurzyna M, Hajduk B, Biederman A, Torbicki A. Vascular complications in a 51-year-old female with a primary antiphospholipd syndrome–a case report. Kardiol Pol. 2007;65:50–3.PubMedGoogle Scholar
  39. 39.
    Cianciulli TF, Saccheri MC, Lax JA, Neme RO, Sevillano JF, Maiori ME, et al. Left ventricular thrombus mimicking primary cardiac tumor in a patient with primary antiphospholipid syndrome and recurrent systemic embolism. Cardiol J. 2009;16:560–3.PubMedGoogle Scholar
  40. 40.
    de Agustín JA, Nuñez-Gil IJ, Ruiz-Mateos B, Manzano Mdel C, Vivas D, de Isla LP, et al. Calcified right ventricular thrombus and antiphospholipid syndrome. Eur J Echocardiogr. 2009;10:471–2.PubMedCrossRefGoogle Scholar
  41. 41.
    Alaminos García P, Menduiña GMJ, De La Chica Ruiz-Ruano R. Prosthetic valve thrombosis in a patient with antiphospholipid syndrome. Report of one case. Rev Med Chil. 2010;138:330–3.PubMedGoogle Scholar
  42. 42.
    Kondo H, Nakayama M, Ishikawa H. Mitral valve replacement for mitral valve stenosis and insufficiency in a patient with antiphospholipid syndrome and systemic lupus erythematosus; report of a case. Kyobu Geka. 2010;63:1173–5.PubMedGoogle Scholar
  43. 43.
    Kim HW, Hong TH, Moon MH, Jo KH. Postoperative acute superior mesenteric venous thrombosis after cardiac surgery in a patient with anti-phospholipid syndrome. Eur J Cardiothorac Surg. 2010;37:1230.PubMedCrossRefGoogle Scholar
  44. 44.
    Rawat RS, Mehta Y, Saxena P, Juneja R, Bhan A. Double valve replacement in a patient with antiphospholipid antibody syndrome. Ann Card Anaesth. 2011;14:235–6.PubMedCrossRefGoogle Scholar
  45. 45.
    García-Valentin A, Colli A, Cartaňá R, Pomar JL, Mestres CA. Endocarditis trombótica no bacteriana (Libman-Sachs). Cir Cardiovasc. 2006;13:208.CrossRefGoogle Scholar
  46. 46.
    Amital H, Langevitz P, Levy Y, Afek A, Goldberg I, Pras M, et al. Valvular deposition of antiphospholipid antibodies in the antiphospholipid syndrome: a clue to the origin of the disease. Clin Exp Rheumatol. 1999;17:99–102.PubMedGoogle Scholar
  47. 47.
    Hogan WJ, McBane RD, Santrach PJ, Plumhoff EA, Oliver Jr WC, Schaff HV, et al. Antiphospholipid syndrome and perioperative hemostatic management of cardiac valvular surgery. Mayo Clin Proc. 2000;75:971–6.PubMedCrossRefGoogle Scholar
  48. 48.
    Gorki H, Malinovski V, Stanbridge RDL. The antiphospholipid syndrome and heart valve surgery. Eur J Cardiothorac Surg. 2008;33:168–81.PubMedCrossRefGoogle Scholar
  49. 49.
    Erdozain JG, Ruiz-Irastorza G, Segura MI, Amigo MC, Espinosa G, Pomar JL, et al. Cardiac valve replacement in patients with antiphospholipid syndrome. Arthritis Care Res (Hoboken). 2012;64(8):1256–60. doi:10.1002/acr.21670.PubMedGoogle Scholar

Copyright information

© Springer-Verlag London 2013

Authors and Affiliations

  • Carlos A. Mestres
    • 1
    Email author
  • Cecilia Marcacci
    • 1
  • Gerard Espinosa
    • 2
  • Jose L Pomar
    • 1
  • Andrea Colli
    • 3
  • Ricard Cervera
    • 2
  1. 1.Department of Cardiovascular SurgeryHospital Clinico, University of BarcelonaBarcelonaSpain
  2. 2.Department of Autoimmune DiseasesHospital Clinico, University of BarcelonaBarcelonaSpain
  3. 3.Department of Cardiovascular Surgery, Cardiac Surgery UnitUniversity of PadovaPadovaItaly

Personalised recommendations